
Myeloid Therapeutics
Focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases.
Employees
Enterprise value
$292—438m
Authorizing premium user...
Focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases.